Facebook  Twitter  Youtube  ISSUU  RSS  Email


Media Contacts

UK
Dominic Kavakeb
dominic.kavakeb@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Tag Cloud

Allegations anti-bribery anti-corruption summit AntiCorruption anti money laundering bribery BSkyB Cabinet Office companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office journalists Letter Leveson Inquiry London Merkel metropolitan police money laundering moneylaundering offshore tax open governance pharmaceuticals PHP police ethics Prime Minister Register of Interests Research safe havens Social Accountability Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Twitter

TransparencyUK UWOs are an important power in targeting corrupt wealth in the UK and there is no shortage of potential cases - we… https://t.co/Ybt9nV59fv
TransparencyUK RT @thetimes: Tomorrow's front page: UK failing to tackle rich foreign criminals #tomorrowspapertoday https://t.co/79oTNVMUv1
TransparencyUK 👏👏👏 You were right when you said not all heroes wear capes! Congrats from all of us at TI-UK!… https://t.co/Amom5kS0c7

Stay Informed

Sign up for updates on TI-UK's work & corruption news from around the globe.

Recent Blog Posts

Search Blog

Guest blogger Shalni Arora looks at corruption’s impact in the healthcare sector, and reflects on what it means for both the achievement of the new development goals as well as universal health coverage.

Corruption affects millions of people, and is deeply linked to inequality and underdevelopment around the world. Yet rooting out corruption should not just be the priority and duty of the developing country. Countries like the UK have a major role to play.

To ensure research and development of medical treatments becomes more transparent, Transparency International UK is pleased to support the AllTrials campaign calling for all past and present clinical trials to be registered and their results reported.

In February 2014 the UK media claimed that NHS England had, despite prior knowledge, invited a patients group entirely funded by the pharmaceutical industry and headed by a well-known pharmaceutical industry lobbyist to draft a report which could affect future NHS policy. The group is called the Specialised Healthcare Alliance and its Director, John Murray, also heads a lobbying firm whose clients include some of the world’s biggest drug and medical device firms.

With a worth of US$6.5 trillion, the global healthcare industry is especially vulnerable to corruption. Although the problem is particularly acute in countries where corruption is endemic, no country is immune.

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of